Information for this workshop is available in this REGISTRATION FORM. Please register by COB November 5th. Connection information and additional details for the workshop will be forthcoming after registration.
This workshop will convene key stakeholders from academia, NIH, NIST and FDA to discuss major challenges in the biocompatibility assessment of new dental restorative materials during early stages of product development, explore potential solutions to overcome limitations in predictive preclinical testing and establish opportunities for collaboration in this domain.
There has been increasing research in recent years on the development of new approach methodologies (NAMs, e.g. in vitro or in chemico assays) that can potentially yield similar results to in vivo testing. The focus of this workshop is on NAMs that could be used to predict the biocompatibility of dental materials. In materials research, these NAMs could be used to identify biocompatibility related problems earlier in the design process and enable process or material component changes prior to investing significant resources into regulatory procedures. We will also focus on recent work that has been conducted to use quality tools to improve measurement confidence in NAMs.